Wang Wang Selected Research

Iron

6/2021	Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer.
1/2017	Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
12/2015	Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wang Wang Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 05/2008
15	Heart Failure 01/2021 - 05/2008
14	Hypoxia (Hypoxemia) 10/2021 - 01/2008
12	Inflammation (Inflammations) 03/2021 - 02/2011
8	Pulmonary Hypertension 07/2020 - 09/2013
8	Fibrosis (Cirrhosis) 12/2017 - 02/2011
7	Cardiomegaly (Heart Hypertrophy) 01/2022 - 06/2012
6	Ischemia 01/2022 - 12/2008
6	Myocardial Infarction 01/2022 - 07/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 01/2012
6	Heart Diseases (Heart Disease) 05/2018 - 11/2008
5	Neointima 05/2022 - 01/2020
5	Cardiomyopathies (Cardiomyopathy) 01/2020 - 03/2014
5	Wounds and Injuries (Trauma) 01/2019 - 05/2005
5	Hypertrophy 01/2018 - 03/2014
4	COVID-19 03/2022 - 01/2021
4	Multiple Myeloma 02/2021 - 09/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2015
4	Right Ventricular Hypertrophy 01/2020 - 12/2014
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 09/2015
3	Hyperplasia 12/2022 - 01/2021
3	Tendinopathy (Tendonitis) 01/2021 - 01/2020
3	Insulin Resistance 12/2020 - 03/2014
3	Vascular Remodeling 01/2020 - 12/2015
3	Obesity 01/2020 - 03/2015
3	Hypertension (High Blood Pressure) 01/2019 - 07/2014
3	Infarction (Infarctions) 08/2017 - 09/2015
3	Reperfusion Injury 07/2013 - 11/2008
2	Carcinogenesis 10/2021 - 04/2019
2	Abdominal Aortic Aneurysm 05/2021 - 01/2019
2	Cognitive Dysfunction 01/2021 - 04/2017
2	Pulmonary Arterial Hypertension 01/2020 - 12/2015
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2012
2	Bronchiectasis 01/2019 - 07/2018
2	Iron Overload 01/2017 - 12/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 11/2008
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2014 - 07/2011
2	Plague (Bubonic Plague) 10/2010 - 09/2009
2	Shock 01/2008 - 05/2005
1	Osteoarthritis 06/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2008
6	Protein Isoforms (Isoforms)IBA 01/2022 - 07/2009
6	ApelinIBA 01/2019 - 01/2012
6	Superoxides (Superoxide)IBA 12/2017 - 07/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016 - 01/2008
5	Pharmaceutical PreparationsIBA 12/2022 - 03/2014
5	Sirolimus (Rapamycin)FDA Link 12/2022 - 12/2014
5	CateninsIBA 02/2021 - 01/2013
5	Peptides (Polypeptides)IBA 10/2019 - 01/2012
5	CalciumIBA 01/2016 - 07/2009
4	EnzymesIBA 11/2021 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2013
4	Angiotensin IIIBA 01/2019 - 02/2011
4	Therapeutic UsesIBA 12/2015 - 01/2012
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2022 - 05/2021
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 09/2015
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 11/2008
3	Interleukin-17 (Interleukin 17)IBA 11/2021 - 01/2019
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2021 - 05/2008
3	IronIBA 06/2021 - 12/2015
3	Angiotensin-Converting Enzyme 2IBA 12/2017 - 02/2011
3	Polysaccharides (Glycans)IBA 05/2017 - 07/2015
3	Matrix Metalloproteinases (MMPs)IBA 12/2014 - 07/2014
3	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2014 - 07/2011
2	HydrogelsIBA 12/2022 - 05/2021
2	AntigensIBA 01/2022 - 09/2021
2	NestinIBA 10/2021 - 01/2020
2	ElastinIBA 10/2021 - 05/2021
2	AntioxidantsIBA 10/2021 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2014
2	Biological ProductsIBA 06/2021 - 01/2021
2	oridoninIBA 06/2021 - 09/2018
2	MicroRNAs (MicroRNA)IBA 02/2021 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
2	LigandsIBA 01/2021 - 12/2015
2	Proteasome InhibitorsIBA 01/2021 - 11/2020
2	Messenger RNA (mRNA)IBA 12/2020 - 07/2014
2	Oxidoreductases (Dehydrogenase)IBA 12/2020 - 06/2013
2	Phosphates (Orthophosphate)IBA 01/2020 - 12/2015
2	MonocrotalineIBA 01/2020 - 12/2015
2	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 01/2016
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 01/2018
2	CytokinesIBA 01/2019 - 10/2016
2	FollistatinIBA 01/2018 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 09/2014
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 05/2008
2	AngiotensinsIBA 12/2017 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2012
2	Metalloproteases (Metalloproteinases)IBA 01/2016 - 09/2015
2	Cyclin D1IBA 12/2015 - 01/2013
2	Mitochondrial Permeability Transition PoreIBA 09/2015 - 07/2008
2	Subunit VaccinesIBA 10/2010 - 09/2009
1	AlginatesIBA 12/2022
1	Hyaluronic Acid (Hyaluronan)IBA 12/2022
1	RhodaminesIBA 12/2022
1	rhyncophyllineIBA 06/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2022

Therapy/Procedure

14	Therapeutics 12/2021 - 05/2008
2	Ovariectomy (Oophorectomy) 01/2022 - 01/2017
2	Intraperitoneal Injections 01/2021 - 01/2020